← Back to Search

Light Therapy for Prostate Cancer

N/A
Recruiting
Led By Lisa M Wu, PhD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Are about to begin external beam radiation therapy (RT) for prostate cancer
Are able to speak or read English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months after the intervention
Awards & highlights

Study Summary

This trial will study whether light exposure can help prevent fatigue in prostate cancer patients during radiation therapy, and how it works.

Who is the study for?
This trial is for adults over 18 with localized prostate cancer who are about to start radiation therapy. They must be able to read or speak English, have internet access, and not have certain conditions like active infections, sleep disorders (excluding insomnia), or a history of light therapy use.Check my eligibility
What is being tested?
The 'PC-LIGHT' Study is testing whether systematic light exposure can prevent fatigue in prostate cancer patients undergoing radiation therapy. It aims to understand how this potential treatment works and improve the quality of life by managing fatigue-related symptoms.See study design
What are the potential side effects?
Since the intervention involves systematic light exposure, side effects may be minimal but could include eye strain or headache. The study excludes those on photosensitizing medications due to increased risk of skin reactions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are going to start radiation therapy for prostate cancer.
Select...
You can understand and communicate in English.
Select...
You are able to connect to the internet.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months after the intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months after the intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Fatigue
Fatigue FACIT-Fatigue scores
Secondary outcome measures
Circadian activity rhythms
Cognitive Functioning
Cognitive functioning
+4 more
Other outcome measures
BMI
Chronotype
Credibility/Expectancy
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention lightExperimental Treatment1 Intervention
30 minutes of intervention systematic light exposure daily for the course of radiation therapy (approximately 8 weeks).
Group II: Comparison lightActive Control1 Intervention
30 minutes of comparison systematic light exposure daily for the course of radiation therapy (approximately 8 weeks).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Intervention systematic light exposure
2016
N/A
~50

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,576 Previous Clinical Trials
911,862 Total Patients Enrolled
5 Trials studying Fatigue
247 Patients Enrolled for Fatigue
Lisa M Wu, PhDPrincipal InvestigatorNorthwestern University
3 Previous Clinical Trials
107 Total Patients Enrolled
1 Trials studying Fatigue
47 Patients Enrolled for Fatigue

Media Library

Intervention systematic light exposure Clinical Trial Eligibility Overview. Trial Name: NCT03419585 — N/A
Intervention systematic light exposure 2023 Treatment Timeline for Medical Study. Trial Name: NCT03419585 — N/A
Fatigue Research Study Groups: Intervention light, Comparison light
Fatigue Clinical Trial 2023: Intervention systematic light exposure Highlights & Side Effects. Trial Name: NCT03419585 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current enrolment size for this experiment?

"Affirmative. As indicated on clinicaltrials.gov, the active recruitment of participants for this medical trial commenced on December 12th 2018 and was most recently updated in February 7th 2022. There is a target quota of 60 individuals across one location."

Answered by AI

Are researchers presently enrolling participants for this clinical investigation?

"This research project is in the process of recruiting participants, as indicated on clinicaltrials.gov. The initial posting was made on December 12th 2018 with a subsequent update issued February 7th 2022."

Answered by AI

What are the objectives of this investigation?

"The primary metric of this study is Fatigue, measured at Baseline. Secondary objectives include Sexual and Urinary Functioning (using the American Urological Association symptom index & Sexual Adjustment Questionnaire), Sleep Quality (assessed through Pittsburgh Sleep Quality Index) and Depressed Mood (as indicated by Center for Epidemiologic Studies Depression Scale). Higher scores are connected to increased levels of symptoms being present."

Answered by AI
~10 spots leftby Mar 2025